MENU

MTVA MetaVia Inc. Forecast, Technical & Fundamental Analysis

MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases... Show more

MTVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
MTVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MTVA is expected to report earnings to fall 6.75% to -73 cents per share on November 16

MetaVia Inc. MTVA Stock Earnings Reports
Q3'26
Est.
$-0.74
Q1'26
Missed
by $0.45
Q4'25
Missed
by $0.52
Q3'25
Beat
by $0.18
Q2'25
Beat
by $0.06
The last earnings report on May 14 showed earnings per share of -79 cents, missing the estimate of -34 cents. With 29.66K shares outstanding, the current market capitalization sits at 9.62M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIRE1.580.15
+10.49%
Realpha Tech Corp.
DXCM92.342.12
+2.35%
DexCom
CRTO17.44-0.05
-0.26%
Criteo SA
FOCL4.13-0.11
-2.59%
Edap TMS SA
PRIM77.18-2.06
-2.60%
Primoris Services Corp

MTVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with PMVP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then PMVP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
+1.39%
PMVP - MTVA
35%
Loosely correlated
+2.31%
SPRB - MTVA
34%
Loosely correlated
-0.78%
KPRX - MTVA
30%
Poorly correlated
+1.53%
IMTX - MTVA
28%
Poorly correlated
+4.44%
ANNX - MTVA
28%
Poorly correlated
-2.12%
More
MetaVia (MTVA) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com